Department of Physiology and Pharmacology, Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON N6A 5C1, Canada.
Neuroscience. 2012 Apr 5;207:88-102. doi: 10.1016/j.neuroscience.2012.01.044. Epub 2012 Feb 6.
Receptors for the calcium-regulating glycoprotein hormone stanniocalcin-1 (STC-1) have been found within the CNS and whether these receptors exist within the nucleus of the solitary tract (NTS), and their possible role in the regulation of arterial pressure (AP) is unknown. Experiments were done in the rat to: (1) map the distribution of STC-1 receptors throughout NTS using in situ ligand binding that uses a stanniocalcin-alkaline phosphatase (STC-AP) fusion protein; (2) determine whether protein and gene expression for STC-1 exists within NTS using immunohistochemistry, Western blot and real time qPCR; (3) determine the effect of microinjection of STC-1 into NTS on AP and the baroreflex. Cells exhibiting STC-1 binding sites were found mainly within the caudal medial (Sm), gelantinous and commissural subnuclei of NTS. Cells containing STC-1 immunoreactivity were found to overlap those regions of NTS that contained STC-1 receptors. STC-1 protein and gene expression were also found within caudal NTS. In chloralose-urethane-anesthetized rats, microinjections of STC-1 (1.76-176 nM; 20 nl) into the caudal Sm elicited a dose-related decrease in AP. In contrast, injections of a nonbioactive form of STC-1 (STC-1+guanosine 5'-triphosphate [GTP]), the vehicle (0.9% saline), or GTP alone did not elicit cardiovascular responses. Additionally, injection of STC-1 into Sm potentiated the AP responses to electrical stimulation of the ipsilateral aortic depressor nerve. Finally, bilateral injection of STC-1 primary antiserum (1:1000; 100 nl) into Sm elicited a long lasting increase in AP, whereas microinjection of heat inactivated STC-1 antiserum did not alter AP. Taken together these data suggest that endogenous STC-1 signaling in NTS is involved in regulating the excitability of neurons that normally function as components of the baroreceptor reflex controlling AP.
钙调节糖蛋白激素 STC-1(STC-1)的受体已在中枢神经系统中发现,这些受体是否存在于孤束核(NTS)中,以及它们在调节动脉压(AP)中的可能作用尚不清楚。在大鼠中进行了实验:(1)使用原位配体结合,该方法使用 STC-碱性磷酸酶(STC-AP)融合蛋白,绘制整个 NTS 中 STC-1 受体的分布图谱; (2)使用免疫组织化学,Western blot 和实时 qPCR 确定 NTS 中是否存在 STC-1 的蛋白和基因表达; (3)确定 STC-1 微注射到 NTS 对 AP 和压力反射的影响。发现具有 STC-1 结合位点的细胞主要存在于 NTS 的尾侧内侧(Sm),凝胶状和连合亚核中。发现含有 STC-1 免疫反应性的细胞与包含 STC-1 受体的 NTS 区域重叠。还在尾侧 NTS 中发现了 STC-1 蛋白和基因表达。在氯醛-尿烷麻醉的大鼠中,将 STC-1(1.76-176 nM; 20 nl)微注射到尾侧 Sm 中引起 AP 呈剂量相关的降低。相比之下,注射非生物活性形式的 STC-1(STC-1+鸟苷 5'-三磷酸[GTP]),载体(0.9%盐水)或 GTP 本身不会引起心血管反应。此外,将 STC-1 注射到 Sm 中增强了对同侧主动脉降压神经电刺激的 AP 反应。最后,将 STC-1 初级抗血清(1:1000; 100 nl)双侧注射到 Sm 中引起 AP 长时间升高,而热失活的 STC-1 抗血清微注射则不改变 AP。总之,这些数据表明 NTS 中的内源性 STC-1 信号参与调节通常作为控制 AP 的压力感受器反射的组成部分的神经元的兴奋性。